
    
      324 patients will be included in this study: 159 in cohort 1 and 165 in cohort 2. The cohort
      1 will be focused on participants with Type 1 or Type 2 Diabetes with an HbA1c > 8% whereas
      cohort 2 will be focused on participants with Type 1 Diabetes spending more than 1.5 hour
      with sensor glucose < 70 mg/dL per day including excursions below 54 mg/dL as a mean for at
      least 28 days.
    
  